The present invention relates to substituted pyrazolopyridinamine compounds of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative and/or angiogenesis disorder, inflammatory disease and disease associated with inflammatory pain, as a sole agent or in combination with other active ingredients.本發明係關於如本文所描述及定義之通式(I)之經取代之吡唑并吡啶胺化合物，製備該等化合物之方法，可用於製備該等化合物之中間化合物，包含該等化合物之醫藥組合物及組合，以及該等化合物於製造醫藥組合物之用途，該化合物作為唯一藥劑或與其他活性成分組合，用於治療或預防疾病，特別是過度增生及/或血管生成病症、發炎疾病及與發炎性疼痛相關之疾病。
